Protara Therapeutics Inc. (NASDAQ: TARA) Stock Information | RedChip

Protara Therapeutics Inc. (NASDAQ: TARA) Listen to this Section


$2.07
+0.0150 ( +0.73% ) 186.9K

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Market Data


Open


$2.07

Previous close


$2.05

Volume


186.9K

Market cap


$41.47M

Day range


$2.00 - $2.12

52 week range


$1.04 - $5.24

Insider Ownership Transactions

Total Amount Purchased: -51,915.00 | $ -107,204.48

Date Type Amount Purchased Purchaser
2024-01-23 Sale -23000.00 Zummo Jacqueline
2024-01-23 Sale -8000.00 Fry Hannah
2024-01-12 Sale -5746.00 Shefferman Jesse
2024-01-12 Sale -5229.00 Zummo Jacqueline
2024-01-12 Sale -1877.00 Bandari Jathin
2024-01-05 Sale -1899.00 Zummo Jacqueline
2024-01-05 Sale -5840.00 Shefferman Jesse
2024-01-05 Sale -324.00 Fry Hannah

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 May 02, 2024
10-q Quarterly Reports 74 May 02, 2024
def Proxies and info statements 5 Apr 26, 2024
ars Annual reports 1 Apr 26, 2024
8-k 8K-related 63 Apr 05, 2024
8-k 8K-related 14 Mar 18, 2024
10-k Annual reports 96 Mar 13, 2024
8-k 8K-related 16 Mar 13, 2024
4 Insider transactions 1 Jan 23, 2024
4 Insider transactions 1 Jan 23, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.